Actelion Pharmaceuticals US Selects I-many/Medicaid.Business/Technology Editors & Health/Medical Writers Rapid Implementation of I-many Solution Enables Emerging Biopharmaceutical Company to Streamline Medicaid Compliance I-many, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : IMNY IMNY Internet Marketers of New York ), the leader in enterprise contract management and trade management solutions, announced today that Actelion Pharmaceuticals US has selected and successfully implemented I-many/Medicaid, allowing the biopharmaceutical company to automatically process and validate claims from State Medicaid rebate programs. The rapid implementation of I-many/Medicaid allows Actelion to market their first product, Tracleer, and support the product's participation in the Medicaid program. With I-many/Medicaid, Actelion is well positioned to handle Medicaid processing requirements of future products. Actelion Pharmaceuticals US, Inc., is owned by Actelion Ltd, a biopharmaceutical company headquartered in Allschwil, Switzerland. The company is a leading player in innovative science related to the endothelium endothelium /en·do·the·li·um/ (-the´le-um) pl. endothe´lia the layer of epithelial cells that lines the cavities of the heart, the serous cavities, and the lumina of the blood and lymph vessels. - the single layer of cells separating every blood vessel blood vessel n. An elastic tubular channel, such as an artery, a vein, a sinus, or a capillary, through which the blood circulates. blood vessel(s), n the network of muscular tubes that carry blood. from the blood stream. It focuses on the discovery, development and marketing of innovative drugs for significant unmet medical needs. The parent company's shares are traded on the Swiss Stock Exchange (SWX SWX Swiss Exchange (trademark of SWX Swiss Exchange) SWX SolidWorks (3D solid modeling CAD software) SWX Splitter / Wave Division Multiplexer New Market ATLN). Actelion currently markets Tracleer for the treatment of Pulmonary Arterial Hypertension (PAH PAH, PAHA aminohippuric acid. PAH abbr. para-aminohippuric acid PAH 1 Polycyclic aromatic hydrocarbon, see there 2. Pulmonary artery HTN ) in patients with WHO Class III or IV symptoms to improve exercise ability and decrease the rate of clinical worsening. Tracleer is sold under two national drug codes. Actelion viewed I-many/Medicaid as a strategic purchase for its projected growth. "We were looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. a solution that would provide us with all the capabilities required for compliance with Medicaid programs," said Linda Schock, Manager Distribution and Reimbursement, Actelion Pharmaceuticals US. "I-many/Medicaid is established in the industry and will satisfy our needs in this area as we grow as a company." "I-many/Medicaid is a recognized solution for the government's legislation on the Medicaid drug rebate program and we have provided solutions for this program since its inception, which was over 10 years ago," said Adam Fine, General Manager, Life Sciences, at I-many. "We're excited about the opportunity to service an emerging life science company. By helping Actelion go live in a quick timeframe, I-many has again proved its ability to successfully deliver sophisticated contract management solutions." About I-many/Medicaid I-many/Medicaid is the only ready-to-install software solution that provides the functionality and reporting required to maintain compliance with the Medicaid Drug Rebate Laws. About I-many I-many (NASDAQ: IMNY) is the leading provider of enterprise contract management and trade management solutions. The company's solutions automate contracting processes, ensure contract compliance and track contract performance resulting in higher contract revenues and reduced operating costs operating costs npl → gastos mpl operacionales . More than 250 life science, consumer goods consumer goods Any tangible commodity purchased by households to satisfy their wants and needs. Consumer goods may be durable or nondurable. Durable goods (e.g., autos, furniture, and appliances) have a significant life span, often defined as three years or more, and , food service and manufacturing companies use I-many solutions. For more information, visit the company at http://www.imany.com. This press release may contain forward-looking statements relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc the future performance of I-many, Inc. Forward-looking statements, specifically those concerning future performance, are subject to certain risks and uncertainties, and actual results may differ materially from expectations. These risks and uncertainties include the customary uncertainty associated with large software implementation projects and other risks described in I-many's filings with the Securities and Exchange Commission. All trademarks are the property of their respective owners. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion